| Literature DB >> 31138861 |
Yaozong Wang1,2, Naikun Sun3, Yinlong Zhang4, Bin Zhao4, Zheyi Zhang5, Xu Zhou6, Yuanyuan Zhou4, Hongyi Liu4, Ying Zhang2, Jianguo Liu7.
Abstract
This study explored the applicability, cellular efficacy, and osteogenic activities of porous class="Chemical">nano-hydroxyapatite/Entities:
Mesh:
Substances:
Year: 2019 PMID: 31138861 PMCID: PMC6538636 DOI: 10.1038/s41598-019-44478-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Chemical characterizations of PGS-g-M scaffolds and PGS-M-n-HA-0.4, PGS-M-n-HA-0.5, and PGS-M-n-HA-0.6 composite scaffolds. (A) The 1H-NMR spectrogram of PGS-g-M. (B) The FT-IR spectrogram of n-HA powder, PGS-g-M scaffolds, and PGS-M-n-HA-0.4, PGS-M-n-HA-0.5, and PGS-M-n-HA-0.6 composite scaffolds.
Figure 2SEM images of the PGS-g-M scaffolds (A) and the PGS-M-n-HA-0.4 (B), PGS-M-n-HA-0.5 (C), and PGS-M-n-HA-0.6 composite scaffolds (D).
Figure 3Physical characterizations of PGS-g-M scaffolds and PGS-M-n-HA-0.4, PGS-M-n-HA-0.5, and PGS-M-n-HA-0.6 composite scaffolds. (A) Differential scanning calorimetry (DSC) curves; (B) thermogravimetric analysis (TGA) curves; (C) the stress-strain curve; (D) the modulus of compressibility graphs.
Figure 4The biomedical applications of PGS-M-n-HA-0.4, PGS-M-n-HA-0.5, and PGS-M-n-HA-0.6 composite scaffolds in bone regeneration in vitro. (A) the effects of these scaffolds on cell proliferation in human adipose-derived stem cells (hADSCs); (B) the expression levels of proinflammatory factor IL-6, and the expression levels of genes associated with osteoblast differentiation by qRT-PCR; The levels of RUNX2, OCN proteins by western blot (C) and immunohistochemical staining (D).
Figure 5SEM images of scaffolds in simulated body fluid (SBF) from 1 week to 4 weeks. The upper left corner: magnification of SEM images.
Figure 6The reaction scheme for the synthesis of PGS-g-M. PGS-g-M, poly (glycerol sebacate)-graft-Maleic anhydride.
The primers in real-time quantitative PCR assay.
| Primers | Sequence (5′-3′) |
|---|---|
| human-GAPDHF | AGAAGGCTGGGGCTCATTTG |
| human-GAPDHR | AGGGGCCATCCACAGTCTTC |
| IL-6-hF | ATGAGGAGACTTGCCTGGTG |
| IL-6-hR | GCATTTGTGGTTGGGTCAGG |
| RUNX2-hF | CCGCCTCAGTGATTTAGGGC |
| RUNX2-hR | GGGTCTGTAATCTGACTCTGTCC |
| BMP2-hF | GAACGGACATTCGGTCCTTG |
| BMP2-hR | GCAACGCTAGAAGACAGCG |
| COL1A1-hF | CTGGCCTCCCTGGAATGAAG |
| COL1A1-hR | GGCAGCACCAGTAGCACC |
| OCN-hF | GGATGACCCCCAAATAGCCC |
| OCN-hR | CTTGGACACAAAGGCTGCAC |
hF, human forward primer; hR, human reversed primer.